GGrantIndex
← Search

Adjuvant Development for a Thermostable Respiratory Influenza Vaccine

$599,749N01FY2018AINIH

Universal Stabilization Technologies, San Diego CA

Investigators

Abstract

The project is to develop synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs and delta-inulin as adjuvants within the context an influenza vaccine.

View original record on NIH RePORTER →